FDA Adverse Event
Injury
Summary report: N
GORE EXCLUDER AAA ENDOPROSTHESIS
MDR report key: 2233946
·
Received August 30, 2011
Report
- Report Number
- 2017233-2011-00446
- Event Type
- Injury
- Date Received
- August 30, 2011
- Date of Event
- August 11, 2011
- Report Date
- August 29, 2011
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OR, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
A REVIEW OF THE MFG PAPERWORK HAS BEEN CONDUCTED. RESULTS: THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECS.
Description of Event or Problem · 1
ON (B)(6), 2011, THE PT WAS BEING TREATED FOR AN ABDOMINAL AORTIC ANEURYSM USING A GORE EXCLUDER AAA ENDOPROSTHESIS FEATURING C3 DEVICE. THE DEVICE WAS DISPLAYED AT THE DESIRED LOCATION JUST BELOW THE RENAL ARTERIES. AN ANGIOGRAM REVEALED THAT THE PT'S LEFT INTERNAL ILIAC ARTERY WAS UNINTENTIONALLY COVERED. A BALLOON WAS USED TO MOVE THE DISTAL PORTION OF THE IPSILATERAL LEG PROXIMAL ENOUGH TO ALLOW FOR PARTIAL BLOOD FLOW INTO THE LEFT INTERNAL ILIAC ARTERY. THE PROXIMAL PORTION OF THE TRUNK-IPSILATERAL LEG COMPONENT REMAINED AT THE DESIRED LOCATION. THE PT TOLERATED THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GORE EXCLUDER AAA ENDOPROSTHESIS | MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W.L. GORE & ASSOCIATES | WLG425 | 8624415 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 77 YR | Hospitalization| R | THE PT'S MEDICATIONS INCLUDE XANAX| ALEGRA| ASPIRIN| LOVASTATIN| METAPROLOL |